Renovia's leva® Pelvic Health System is First Femtech Offering Included in Product Library of Digital Therapeutics Alliance Prestigious distinction is further evidence that leva® Pelvic Health System meets rigorous standards for high-quality, evidence-based patient...

Meet The Company Offering An Innovative Medication-Free Approach To Better Pelvic Floor Health, Bringing Female Urinary Incontinence Out Of The Closet Marija Butkovic 12:26am EDT ForbesWomen I write about innovative tech companies and women behind them. Almost 50% of...

Study shows leva® Digital Therapeutic improves fecal incontinence symptoms Women with accidental bowel leakage experience "significant improvement" in 10-week study NEWS PROVIDED BY Renovia May 25, 2021, 09:00 ET BOSTON, May 25, 2021 /PRNewswire/ -- Renovia Inc....

Renovia raises $17M in Series C-1 financing Proceeds to advance U.S. commercial launch of leva® Digital Therapeutic and additional clinical development Renovia Inc. Apr 19, 2021, 09:00 ET BOSTON, April 19, 2021 /PRNewswire/ -- Renovia Inc. ("Renovia"), a women-led...

Renovia names new president and CEO; completes enrollment for randomized controlled trial Women-led team achieves key milestone ahead of schedule Boston, Mass.—January 19, 2021—Renovia Inc. (“Renovia”), a women-led company that develops digital therapeutics for female...

Renovia presents at Piper Sandler Healthcare Conference Medical Technology Disruptors Panel includes Renovia’s leva® Digital Therapeutic, a novel approach for an underreported disorder affecting 20 million women in the U.S. Boston, Mass.—December 1, 2020—Renovia Inc....

Boston, MA – November 25, 2019 – Renovia Inc. (“Renovia”), a company dedicated to discovering and delivering first-line digital therapeutic and diagnostic device and app technologies for women with pelvic floor disorders, today announced U.S. Food and Drug Administration (FDA) 510(k) clearance for the next-generation leva® Pelvic Digital Therapeutic for the strengthening of pelvic floor muscles and the treatment of stress, mixed and mild to moderate urgency urinary incontinence (UI) in women.

Study Demonstrates Improvements in Objective Pelvic Floor Muscle Measures, Patient-Reported Urinary Incontinence Severity and Condition-Specific Quality of Life, with Results Evident after 1 Week of Use

Boston, MA – March 28, 2019 – Renovia Inc. (“Renovia”), a company dedicated to discovering and delivering first-line digital therapeutic and diagnostic devices for women with pelvic floor disorders, today announced that it has received a nomination for MedTech Company...

Boston, MA – March 14, 2019– Renovia Inc. (“Renovia”), a company dedicated to discovering and delivering first-line digital therapeutic and diagnostic devices for women with pelvic floor disorders, today announced Jim O’Connor has been promoted to General Counsel...

Boston, MA – January 9, 2019– Renovia Inc. ("Renovia"), a company dedicated to discovering and delivering first-line digital therapeutic and diagnostic devices for women with pelvic floor disorders, today announced John A. Fallon, M.D. has joined its Board of...

Six-Center Study Will Compare Renovia's Pelvic Digital Therapeutic System to Standard of Care Pelvic Floor Muscle Exercises in Home-based Treatment of Stress-dominant Urinary Incontinence Boston, MA – November 12, 2018 – Renovia Inc. ("Renovia"), a company dedicated...

Boston, MA – October 31, 2018– Renovia Inc. (“Renovia”), a company dedicated to discovering and delivering first-line digital therapeutic and diagnostic devices for women with pelvic floor disorders, today announced Tara Butler, M.D. has joined its Board of Directors....

Boston, MA – Sept 12, 2018– Renovia Inc. (“Renovia”), a company dedicated to discovering and delivering first-line digital therapeutic and diagnostic devices for women with pelvic floor disorders, today announced Dan Levangie has joined its Board of Directors. "Dan...

Renovia is Developing a Product Pipeline to Better Diagnose and Treat Women Affected by Pelvic Floor Disorders, including Urinary Incontinence Boston, MA – August 28, 2018 – Renovia Inc. ("Renovia"), a company dedicated to discovering and delivering first-line digital...

Financing Will Accelerate Clinical Research, Development and New Digital Therapeutic Device Launches Targeted at Pelvic Floor Disorders Boston, MA – August 21, 2018 – Renovia Inc. ("Renovia"), a company dedicated to discovering and delivering first-line digital...